SCHEMBL24326710

SCHEMBL24326710

Cc1cc(-c2ccccc2C)nc(N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)n1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 6/20 0.40
SDHB P21912 1/20 0.36
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPT P10636 1/20 0.34
PAX8 Q06710 1/20 0.34
ACACB O00763 1/20 0.34
ACACA Q13085 1/20 0.34
HSP90AA1 P07900 1/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TACR3 P29371 1/20 0.34
GPBAR1 Q8TDU6 1/20 0.33
GAA P10253 1/20 0.33
CYP1A2 P05177 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
TACR1 P25103 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24326460 0.88 HSP90AA1 (0.40) SDHBMEN1POLBKMT2APAX8
SCHEMBL4444719 0.78 PPID (0.36) CRHR1MEN1KMT2AMAPTALDH1A1
SCHEMBL24298823 0.77 L3MBTL1 (0.39) HSP90AA1ALDH1A1SMN1; SMN2NPSR1
SCHEMBL4439238 0.74 SMN1; SMN2 (0.36) POLBKMT2AACACBACACAHSP90AA1
SCHEMBL22502015 0.74 HSP90AA1 (0.41) PAX8ACACBACACAHSP90AA1
SCHEMBL24309477 0.73 HSP90AA1 (0.36) PAX8ACACBACACAHSP90AA1
SCHEMBL29566720 0.73 HSP90AA1 (0.36) PAX8ACACBACACAHSP90AA1
SCHEMBL4437706 0.72 TRPV1 (0.42) POLBNPSR1TACR3
SCHEMBL1881782 0.71 SSTR4 (0.37) MEN1KMT2APAX8
SCHEMBL22304529 0.70 ADORA2A (0.38) HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076625-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed